BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 17525835)

  • 1. Overexpression of RhoE has a prognostic value in non-small cell lung cancer.
    Zhang C; Zhou F; Li N; Shi S; Feng X; Chen Z; Hang J; Qiu B; Li B; Chang S; Wan J; Shao K; Xing X; Tan X; Wang Z; Xiong M; He J
    Ann Surg Oncol; 2007 Sep; 14(9):2628-35. PubMed ID: 17525835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of immunohistochemical Rac1 expression in survival in early operable non-small cell lung cancer.
    Yuan K; Qian C; Zheng R
    Med Sci Monit; 2009 Nov; 15(11):BR313-9. PubMed ID: 19865048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
    Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB
    Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of collagen XVIII and its prognostic value in nonsmall cell lung carcinoma.
    Chang H; Iizasa T; Shibuya K; Iyoda A; Suzuki M; Moriya Y; Liu TL; Hiwasa T; Hiroshima K; Fujisawa T
    Cancer; 2004 Apr; 100(8):1665-72. PubMed ID: 15073855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of telomere-associated genes as prognostic markers for overall survival in patients with non-small cell lung cancer.
    Lin X; Gu J; Lu C; Spitz MR; Wu X
    Clin Cancer Res; 2006 Oct; 12(19):5720-5. PubMed ID: 17020976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of cyclin D1 splice variants is differentially associated with outcome in non-small cell lung cancer patients.
    Li R; An SJ; Chen ZH; Zhang GC; Zhu JQ; Nie Q; Xie Z; Guo AL; Mok TS; Wu YL
    Hum Pathol; 2008 Dec; 39(12):1792-801. PubMed ID: 18715616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of CD40 with juxtacrine activity in human nonsmall lung cancer cells correlates with poor prognosis.
    Ishikawa K; Miyamoto M; Yoshioka T; Kato T; Kaji M; Ohbuchi T; Hirano S; Itoh T; Dosaka-Akita H; Kondo S
    Cancer; 2008 Aug; 113(3):530-41. PubMed ID: 18548529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear and cytoplasmic cellular distribution of survivin as survival predictor in resected non-small-cell lung cancer.
    Bria E; Visca P; Novelli F; Casini B; Diodoro MG; Perrone-Donnorso R; Botti C; Sperduti I; Facciolo F; Milella M; Cecere FL; Cognetti F; Mottolese M
    Eur J Surg Oncol; 2008 May; 34(5):593-8. PubMed ID: 17693049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles for USF-2 in lung cancer proliferation and bronchial carcinogenesis.
    Ocejo-Garcia M; Baokbah TA; Ashurst HL; Cowlishaw D; Soomro I; Coulson JM; Woll PJ
    J Pathol; 2005 Jun; 206(2):151-9. PubMed ID: 15856526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiƶ J
    Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer.
    Fukuoka J; Fujii T; Shih JH; Dracheva T; Meerzaman D; Player A; Hong K; Settnek S; Gupta A; Buetow K; Hewitt S; Travis WD; Jen J
    Clin Cancer Res; 2004 Jul; 10(13):4314-24. PubMed ID: 15240517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Retinoid expression (RARbeta and CRBP1) in non-small-cell lung carcinoma].
    Mauro LV; Dalurzo M; Smith D; Lastiri J; Vasallo B; Joffei EB; Pallotta MG; Puricelli L
    Medicina (B Aires); 2008; 68(3):205-12. PubMed ID: 18689151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel.
    Azuma K; Sasada T; Kawahara A; Takamori S; Hattori S; Ikeda J; Itoh K; Yamada A; Kage M; Kuwano M; Aizawa H
    Lung Cancer; 2009 Jun; 64(3):326-33. PubMed ID: 18977553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of transcription factor Pokemon in non-small cell lung cancer and its clinical significance.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Fu K; Zhang J
    Chin Med J (Engl); 2008 Mar; 121(5):445-9. PubMed ID: 18364119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of SEZ6L2 cell-surface protein as a novel prognostic marker for lung cancer.
    Ishikawa N; Daigo Y; Takano A; Taniwaki M; Kato T; Tanaka S; Yasui W; Takeshima Y; Inai K; Nishimura H; Tsuchiya E; Kohno N; Nakamura Y
    Cancer Sci; 2006 Aug; 97(8):737-45. PubMed ID: 16863507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer.
    Imai H; Kaira K; Oriuchi N; Yanagitani N; Sunaga N; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
    Histopathology; 2009 Jun; 54(7):804-13. PubMed ID: 19635099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of MAGE-A transcripts in bone marrow is an independent prognostic factor in operable non-small-cell lung cancer.
    Sienel W; Mecklenburg I; Dango S; Ehrhardt P; Kirschbaum A; Passlick B; Pantel K
    Clin Cancer Res; 2007 Jul; 13(13):3840-7. PubMed ID: 17606715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of survivin mRNA might be a marker for non-invasive detection of non-small cell lung cancer rather than for prognosis.
    Warnecke-Eberz U; Baldus SE; Bollschweiler E; Hoelscher AH; Metzger R
    Anticancer Res; 2008; 28(3A):1525-9. PubMed ID: 18630507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoplasmic clusterin expression is associated with longer survival in patients with resected non small cell lung cancer.
    Albert JM; Gonzalez A; Massion PP; Chen H; Olson SJ; Shyr Y; Diaz R; Lambright ES; Sandler A; Carbone DP; Putnam JB; Johnson DH; Lu B
    Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1845-51. PubMed ID: 17855704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.